Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
Definitive Healthcare (Nasdaq: DH) has announced the granting of inducement awards to its newly hired senior leader. The company's Human Capital Management and Compensation Committee approved inducement awards for Jeff Moyer, who joins as SVP of Growth and Sales Operations.
The awards include 364,432 time-based restricted stock units (RSUs), effective April 3, 2025. The RSUs will vest according to the following schedule: 25% on April 1, 2026, with the remaining amount vesting in quarterly installments of 6.25% over the subsequent three years. These awards were granted under Definitive Healthcare's 2023 Inducement Plan and comply with Nasdaq Listing Rule 5635(c)(4).
Definitive Healthcare (Nasdaq: DH) ha annunciato l'assegnazione di premi di incentivazione al suo nuovo leader senior. Il Comitato per la Gestione del Capitale Umano e la Compensazione dell'azienda ha approvato premi di incentivazione per Jeff Moyer, che si unisce come SVP di Crescita e Operazioni di Vendita.
I premi includono 364.432 unità di azioni vincolate basate sul tempo (RSU), con effetto dal 3 aprile 2025. Le RSU matureranno secondo il seguente programma: 25% il 1 aprile 2026, con il restante importo che maturerà in rate trimestrali del 6,25% nei successivi tre anni. Questi premi sono stati concessi nell'ambito del Piano di Incentivazione 2023 di Definitive Healthcare e sono conformi alla Regola di Quotazione Nasdaq 5635(c)(4).
Definitive Healthcare (Nasdaq: DH) ha anunciado la concesión de premios de incentivo a su nuevo líder senior. El Comité de Gestión del Capital Humano y Compensación de la empresa aprobó premios de incentivo para Jeff Moyer, quien se une como SVP de Crecimiento y Operaciones de Ventas.
Los premios incluyen 364,432 unidades de acciones restringidas basadas en el tiempo (RSUs), que entrarán en vigor el 3 de abril de 2025. Las RSUs se consolidarán según el siguiente cronograma: 25% el 1 de abril de 2026, con el monto restante consolidándose en cuotas trimestrales del 6.25% durante los tres años siguientes. Estos premios se otorgaron bajo el Plan de Incentivo 2023 de Definitive Healthcare y cumplen con la Regla de Cotización 5635(c)(4) de Nasdaq.
디피니티브 헬스케어(나스닥: DH)는 새로 고용된 고위 리더에게 유인 보상을 부여한다고 발표했습니다. 회사의 인적 자원 관리 및 보상 위원회는 제프 모이어에게 유인 보상을 승인했으며, 그는 성장 및 판매 운영의 SVP로 합류합니다.
보상에는 364,432개의 시간 기반 제한 주식 단위(RSU)가 포함되며, 2025년 4월 3일부터 효력을 발휘합니다. RSU는 다음 일정에 따라 분배됩니다: 2026년 4월 1일에 25%, 나머지 금액은 이후 3년 동안 분기별로 6.25%씩 분배됩니다. 이 보상은 디피니티브 헬스케어의 2023 유인 계획에 따라 부여되었으며, 나스닥 상장 규칙 5635(c)(4)를 준수합니다.
Definitive Healthcare (Nasdaq: DH) a annoncé l'octroi de récompenses d'incitation à son nouveau leader senior. Le Comité de Gestion des Ressources Humaines et de Rémunération de l'entreprise a approuvé des récompenses d'incitation pour Jeff Moyer, qui rejoint en tant que SVP de la Croissance et des Opérations de Vente.
Les récompenses comprennent 364 432 unités d'actions restreintes basées sur le temps (RSU), effectives à partir du 3 avril 2025. Les RSU seront acquises selon le calendrier suivant : 25 % le 1er avril 2026, le reste étant acquis en versements trimestriels de 6,25 % sur les trois années suivantes. Ces récompenses ont été accordées dans le cadre du Plan d'Incitation 2023 de Definitive Healthcare et sont conformes à la Règle de Cotation Nasdaq 5635(c)(4).
Definitive Healthcare (Nasdaq: DH) hat die Gewährung von Anreizprämien an seinen neu eingestellten Senior Leader bekannt gegeben. Der Ausschuss für Human Capital Management und Vergütung des Unternehmens genehmigte Anreizprämien für Jeff Moyer, der als SVP für Wachstum und Vertriebsoperationen eintritt.
Die Prämien umfassen 364.432 zeitbasierte Restricted Stock Units (RSUs), die ab dem 3. April 2025 wirksam sind. Die RSUs werden gemäß dem folgenden Zeitplan fällig: 25% am 1. April 2026, wobei der verbleibende Betrag in vierteljährlichen Raten von 6,25% über die folgenden drei Jahre fällig wird. Diese Prämien wurden im Rahmen des Anreizplans 2023 von Definitive Healthcare gewährt und entsprechen der Nasdaq-Listing-Regel 5635(c)(4).
- Strategic hire of SVP of Growth and Sales Operations indicates focus on business expansion
- Structured vesting schedule helps retain key talent over 4-year period
- Potential dilution of shareholders due to issuance of 364,432 new RSUs
FRAMINGHAM, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of one senior leader, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare’s Board of Directors granted inducement awards. The Committee granted Jeff Moyer, Definitive Healthcare’s new SVP of Growth and Sales Operations, an inducement award consisting of 364,432 time-based restricted stock units (“RSUs”), effective April 3, 2025. These awards were individually negotiated and granted as an inducement material to Mr. Moyer’s respective commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4).
Each of the awards is subject to the terms and conditions of Definitive Healthcare’s 2023 Inducement Plan (the “Plan”) and the terms and conditions of an applicable award agreement covering the grant.
Mr. Moyer’s RSUs will vest as follows, subject to Mr. Moyer’s continued employment through each such date: (i)
About Definitive Healthcare
At Definitive Healthcare, our passion is to transform data, analytics, and expertise into healthcare commercial intelligence. We help clients uncover the right markets, opportunities, and people, so they can shape tomorrow’s healthcare industry. Our SaaS platform creates new paths to commercial success in the healthcare market, so companies can identify where to go next. Learn more at definitivehc.com.
Investor Contact:
Brian Denyeau
ICR for Definitive Healthcare
brian.denyeau@icrinc.com
646-277-1251
Media Contact:
Bethany Swackhamer
bswackhamer@definitivehc.com
FAQ
How many RSUs were granted to Jeff Moyer in Definitive Healthcare's (DH) inducement award?
What is the vesting schedule for DH's new SVP of Growth and Sales Operations' RSUs?
When will Jeff Moyer's RSUs begin vesting at Definitive Healthcare (DH)?
Under which plan were DH's inducement awards granted in April 2025?
